Literature DB >> 27841892

Synthetic analogs of stryphnusin isolated from the marine sponge Stryphnus fortis inhibit acetylcholinesterase with no effect on muscle function or neuromuscular transmission.

Lindon W K Moodie1, Monika C Žužek2, Robert Frangež2, Jeanette H Andersen3, Espen Hansen3, Elisabeth K Olsen3, Marija Cergolj4, Kristina Sepčić5, Kine Ø Hansen3, Johan Svenson6.   

Abstract

The marine secondary metabolite stryphnusin (1) was isolated from the boreal sponge Stryphnus fortis, collected off the Norwegian coast. Given its resemblance to other natural acetylcholinesterase antagonists, it was evaluated against electric eel acetylcholinesterase and displayed inhibitory activity. A library of twelve synthetic phenethylamine analogs, 2a-7a and 2b-7b, containing tertiary and quaternary amines respectively were synthesized to investigate the individual structural contributions to the activity. Compound 7b was the strongest competitive inhibitor of both acetylcholinesterase and butyrylcholinesterase with IC50 values of 57 and 20 μM, respectively. This inhibitory activity is one order of magnitude higher than the positive control physostigmine, and is comparable with several other marine acetylcholinesterase inhibitors. The physiological effect of compound 7b on muscle function and neuromuscular transmission was studied and revealed a selective mode of action at the investigated concentration. This data is of importance as the interference of therapeutic acetylcholinesterase inhibitors with neuromuscular transmission can be problematic and lead to unwanted side effects. The current findings also provide additional insights into the structure-activity relationship of both natural and synthetic acetylcholinesterase inhibitors.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27841892     DOI: 10.1039/c6ob02120d

Source DB:  PubMed          Journal:  Org Biomol Chem        ISSN: 1477-0520            Impact factor:   3.876


  5 in total

1.  Structure-Activity Relationship Probing of the Natural Marine Antifoulant Barettin.

Authors:  Christophe Labriere; Gunnar Cervin; Henrik Pavia; Jørn H Hansen; Johan Svenson
Journal:  Mar Biotechnol (NY)       Date:  2021-11-02       Impact factor: 3.619

Review 2.  Marine Pharmacology in 2016-2017: Marine Compounds with Antibacterial, Antidiabetic, Antifungal, Anti-Inflammatory, Antiprotozoal, Antituberculosis and Antiviral Activities; Affecting the Immune and Nervous Systems, and Other Miscellaneous Mechanisms of Action.

Authors:  Alejandro M S Mayer; Aimee J Guerrero; Abimael D Rodríguez; Orazio Taglialatela-Scafati; Fumiaki Nakamura; Nobuhiro Fusetani
Journal:  Mar Drugs       Date:  2021-01-21       Impact factor: 5.118

3.  Spatial Distribution and Stability of Cholinesterase Inhibitory Protoberberine Alkaloids from Papaver setiferum.

Authors:  Neda Safa; Tomaž Trobec; Darren C Holland; Blazej Slazak; Erik Jacobsson; Jeffrey A Hawkes; Robert Frangež; Kristina Sepčić; Ulf Göransson; Lindon W K Moodie; Luke P Robertson
Journal:  J Nat Prod       Date:  2021-12-15       Impact factor: 4.050

Review 4.  Marine Organisms as Alkaloid Biosynthesizers of Potential Anti-Alzheimer Agents.

Authors:  Elisabete Lima; Jorge Medeiros
Journal:  Mar Drugs       Date:  2022-01-15       Impact factor: 5.118

5.  New Metabolites from the Marine Sponge Scopalina hapalia Collected in Mayotte Lagoon.

Authors:  Charifat Saïd Hassane; Gaëtan Herbette; Elnur Garayev; Fathi Mabrouki; Patricia Clerc; Nicole J de Voogd; Stephane Greff; Ioannis P Trougakos; Jamal Ouazzani; Mireille Fouillaud; Laurent Dufossé; Béatrice Baghdikian; Evelyne Ollivier; Anne Gauvin-Bialecki
Journal:  Mar Drugs       Date:  2022-03-02       Impact factor: 5.118

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.